NCT05435391

Brief Summary

This study is a prospective multicenter observational study for external validation and model advancement of a deep learning based 12-lead electrocardiogram analysis algorithm targeting adult patients presenting to the emergency department with chest pain and acute myocardial infarction equivalent symptoms. About 9,000 adult patients will be enrolled at 20 emergency medical centers in Korea. Artificial intelligence algorithms are manufactured by Medical AI Co., Ltd. It is an advanced version based on the model developed and published in 2020. It had the diagnostic performance of area under the receiver operating curve 0.901 and 0.951 for acute myocardial infarction and ST-segment elevation myocardial infarction, respectively. The primary endpoint is a diagnosis of acute myocardial infarction on the day of the emergency center visit, and the secondary endpoint is a 30-day major adverse cardiac event. From March 2022, patient registration will begin at centers that have been approved by the Institutional Review Board. This is the first prospective multicenter emergency department validation study for a 12-lead electrocardiogram artificial intelligence algorithm to diagnose acute myocardial infarction. This study will give insight into the direction of future development by verifying whether the deep learning algorithm works well for patients visiting the real-world adult emergency medical center.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
8,814

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Mar 2022

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 16, 2022

Completed
3 months until next milestone

First Submitted

Initial submission to the registry

June 13, 2022

Completed
15 days until next milestone

First Posted

Study publicly available on registry

June 28, 2022

Completed
8 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 1, 2023

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

May 1, 2023

Completed
Last Updated

June 28, 2022

Status Verified

April 1, 2022

Enrollment Period

12 months

First QC Date

June 13, 2022

Last Update Submit

June 22, 2022

Conditions

Keywords

Deep Learning

Outcome Measures

Primary Outcomes (1)

  • Diagnosis of acute myocardial infarction (Type 1, 2)

    Accuracy metrics include area under the receiver operating characteristics curve, sensitivity, specificity, positive predictive value, and negative predictive value, along with a 95% confidence interval.

    Index admission

Secondary Outcomes (1)

  • Major adverse cardiovascular event (MACE)

    30-day after index admission

Other Outcomes (4)

  • AI ECG analysis versus clinical risk score (HEART score)

    Index admission, 30-day after index admission

  • AI ECG analysis versus clinical risk score (GRACE 2.0 score)

    Index admission, 30-day after index admission

  • AI ECG analysis versus cardiac biomarker

    Index admission

  • +1 more other outcomes

Study Arms (1)

Group 1

Patients with chest pain or who are clinically suspected as acute myocardial infarction with equivalent symptoms.

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

A total of 20 emergency departments in the Republic of Korea will participate in this study. These centers receive about 800,000 patients annually, and all of these hospitals are capable of their own emergency cardiovascular angiography and percutaneous coronary intervention.

You may qualify if:

  • Adults over 18 years of age with suspected chest pain and acute myocardial infarction
  • The onset or worsening of the symptom occurs within 24 hours

You may not qualify if:

  • Out-of-hospital cardiac arrest (OHCA): patients with sustained (\>20 minutes) return-of-spontaneous-circulation are not excluded
  • Patients in whom acute myocardial infarction can be clearly excluded, such as pneumothorax and traumatic chest pain

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

CHA Bundang Medical Center

Seongnam, South Korea

Location

Related Publications (1)

  • Shin TG, Lee Y, Kim K, Lee MS, Kwon JM; ROMIAE study group. ROMIAE (Rule-Out Acute Myocardial Infarction Using Artificial Intelligence Electrocardiogram Analysis) trial study protocol: a prospective multicenter observational study for validation of a deep learning-based 12-lead electrocardiogram analysis model for detecting acute myocardial infarction in patients visiting the emergency department. Clin Exp Emerg Med. 2023 Dec;10(4):438-445. doi: 10.15441/ceem.22.360. Epub 2023 Nov 28.

MeSH Terms

Conditions

Myocardial InfarctionChest Pain

Condition Hierarchy (Ancestors)

Myocardial IschemiaHeart DiseasesCardiovascular DiseasesVascular DiseasesInfarctionIschemiaPathologic ProcessesPathological Conditions, Signs and SymptomsNecrosisPainNeurologic ManifestationsSigns and Symptoms

Study Officials

  • KS Kim, MD, PhD

    CHA University School of Medicine

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

June 13, 2022

First Posted

June 28, 2022

Study Start

March 16, 2022

Primary Completion

March 1, 2023

Study Completion

May 1, 2023

Last Updated

June 28, 2022

Record last verified: 2022-04

Data Sharing

IPD Sharing
Will not share

Locations